PTEN enhances the radiosensitivity of melanoma by inhibiting DNA-PKcs
Frontiers in Cell and Developmental Biology · 15.01.2026 · 13
DOI: 10.3389/fcell.2025.1712429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 15.01.2026. Verfasst von Shengqian Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The phosphatase and tensin homolog ( PTEN ) is a classical tumor-suppressor gene. Its expression deficiency concurrently drives disease progression in approximately 30% of melanomas and is closely associated with radiotherapy tolerance. However, there is a lack of systematic evidence regarding whether and how PTEN regulates the radiosensitivity of melanoma.
Methods
The expression of PTEN was validated using TCGA database, clinical tissue microarrays, and multiple melanoma cell lines. PTEN knockdown (PTEN-KD) and PTEN overexpression (PTEN-OE) stable cell lines were constructed using lentiviral vectors. CCK-8, colony formation assay, annexin V/PI flow cytometry, neutral comet assay, cell-cycle analysis, and Western blotting were used to assess the biological changes in cells after 0 Gy–8 Gy γ-ray irradiation (IR). A cell-derived xenograft model was established, and the tumor volume was observed after local 10 Gy IR for 28 days; in addition, H&E, Ki67, and TUNEL evaluations were performed.
Results
The expression of PTEN in melanoma tissues and cell lines was significantly lower than that in normal controls. IR could induce a transient upregulation of PTEN followed by rapid downregulation. PTEN-OE significantly inhibited proliferation, reduced the clone survival rate, increased apoptosis, and weakened radiation-induced G 2 /M phase arrest; however, the opposite was true for PTEN-KD. Mechanistically, PTEN-OE inhibited the DNA-PKcs axis, reduced NHEJ-mediated rapid repair, and increased the persistent expression of γ-H2AX. PTEN-KD activated the p-ATM/p-Chk2 signaling. Animal experiments confirmed that the tumor volume in the PTEN-OE + IR group was significantly lower than that in the NC + IR group, with an expanded necrotic area, a decreased Ki67 index, and an increased TUNEL-positive rate.
Conclusion
PTEN enhances the radiosensitivity of melanoma by inhibiting the DNA-PKcs signal, weakening NHEJ repair, and delaying cell-cycle recovery. PTEN can serve as a biomarker for radiotherapy response prediction and a target for sensitization intervention, providing an experimental basis for precise radiotherapy strategies for melanoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Reconstructive Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Department of Radiology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Zitieren
APA
Zhu, S., Xu, H., Shen, F., Chen, F., & Wang, Y. (2026). PTEN enhances the radiosensitivity of melanoma by inhibiting DNA-PKcs. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1712429
Vancouver
Zhu S, Xu H, Shen F, Chen F, Wang Y. PTEN enhances the radiosensitivity of melanoma by inhibiting DNA-PKcs. Frontiers in Cell and Developmental Biology. 2026;13. doi:10.3389/fcell.2025.1712429
BibTeX
@article{Zhu2026,
author = {Zhu, Shengqian and Xu, Haitao and Shen, Fu and Chen, Fangying and Wang, Yangjian},
title = {PTEN enhances the radiosensitivity of melanoma by inhibiting DNA-PKcs},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {13},
doi = {10.3389/fcell.2025.1712429}
}
EUVIMED